DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bleau, A.-M.
Right arrow Articles by du Souich, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bleau, A.-M.
Right arrow Articles by du Souich, P.

Vol. 29, Issue 7, 1007-1012, July 2001

SHORT COMMUNICATION
Cytochrome P450 Down-Regulation by Serum from Humans with a Viral Infection and from Rabbits with an Inflammatory Reaction

Anne-Marie Bleau, Caroline Fradette, Ayman O. S. El-Kadi, Marie-Claude Côté, and Patrick du Souich

Department of Pharmacology, Faculty of Medicine, University of Montréal, Montréal, Québec, Canada

Serum from humans with an upper respiratory viral infection (HSURVI) and from rabbits with a turpentine-induced acute inflammatory reaction (RSTIAR) reduces the activity of hepatic cytochrome P450 (P450) following 4 h of incubation. The aim of the present study was to assess the effect of HSURVI and RSTIAR on P450 activity and expression following 24 h of incubation with hepatocytes from control (HCONT) and rabbits with a TIAR (HINFLA). RSTIAR incubated with HCONT for 24 h reduced P450 content and activity, and CYP3A6 by 45%, without changing CYP1A1 and 1A2; when incubated with HINFLA, RSTIAR decreased P450 content and activity without affecting CYP1A1 or 1A2. HSURVI incubated for 4 h with HCONT decreased P450 activity without affecting the amounts of CYP1A1, 1A2, or 3A6, although when incubated for 24 h, P450 activity and CYP3A6 amount decreased. HSURVI incubated with HINFLA for 4 h reduced P450 content and activity, and incubated for 24 h reduced activity, P450 content, and amount of CYP1A1 and 1A2 proteins. The present study demonstrates that 1) the effect of RSTIAR and HSURVI depends upon the susceptibility of the hepatocyte, i.e., HCONT or primed HINFLA; 2) P450 down-regulation is preceded by a decrease in P450 activity; 3) the nature of the inflammatory reaction determines the repercussions on P450 activity and expression; and 4) CYP3A6 is more vulnerable than CYP1A1 and 1A2 to the down-regulation provoked by an inflammatory challenge.


Copyright © 2001 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2001 by the American Society for Pharmacology and Experimental Therapeutics.